Immunomodulatory treatment of interstitial lung disease
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Respiratory Disease"
DOI: 10.1177/17534666221117002
Abstract: Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array of immunomodulatory treatment options compared with IPF, due to their inflammatory component. However, there is a relative paucity of guidance on the… read more here.
Keywords: immunomodulatory treatment; disease; treatment; interstitial lung ... See more keywords
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1086006
Abstract: Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant haematological diseases. Despite continuous improvements in pre- and post-transplantation procedures, the applicability of allo-HSCT is limited by life-threatening complications such as graft-versus-host disease… read more here.
Keywords: immunomodulatory treatment; gvhd; treatment modality; treatment ... See more keywords
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10102620
Abstract: Complex immune response to infection has been highlighted, more than ever, during the COVID-19 pandemic. This review explores the immunomodulatory treatment of moderate-to-severe forms of this viral sepsis in the context of specific immunopathogenesis. Our… read more here.
Keywords: immunomodulatory treatment; cytokine; covid; moderate severe ... See more keywords